4//SEC Filing
Poirier Michael S. 4
Accession 0001493152-21-009359
CIK 0001460702other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 3:18 PM ET
Size
5.3 KB
Accession
0001493152-21-009359
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Purchase
Common Stock
2021-04-20$1.80/sh+11,005$19,809→ 11,005 total(indirect: By IRA)
Holdings
- 169,202
Common Stock
Documents
Issuer
Qualigen Therapeutics, Inc.
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001812504
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 3:18 PM ET
- Size
- 5.3 KB